HOME >> BIOLOGY >> NEWS
Biggest physics meeting of the year

The American Physical Society (APS) March Meeting, usually the biggest physics meeting of the year anywhere, will occur this year March 13-17 at the Baltimore Convention Center by the harbor in Baltimore, Maryland. The March APS Meeting has traditionally been the showcase for the kind of cutting-edge research results that appear, sometimes not so long afterwards, in the new electronic, communications, computer, and medical diagnosis products that have done so much to shape modern culture.

Over 6500 papers will be delivered, some of them in prestigious invited-paper sessions, some in sessions of shorter 10-minute talks, and some in the form of posters. The large disciplinary areas at the meeting will be condensed matter physics, biological physics, chemical physics, new materials, fluid dynamics, polymers, and large-scale computing. Many of the presentations concern fundamental physics discoveries, while many others will look at the progress made toward implementing scientific discoveries in practical devices.

The March Meeting is a place where the latest developments in leading physics research areas (e.g., superconductivity, nanotubes, superfluids, quantum information, ultracold atoms) are reported and where whole new subjects are represented for the first time (e.g., fast electrons in graphene, session D2). The diversity of session subjects is abundant: planetary interiors (A42), ultrafast chemistry (R13), liquid splashing (P8), biological swarming (G8), optical clocks (K1), snake infrared vision (Y26), nanoplumbing (N26.4), Bose-Einstein transistors (B43.10), serial crystallography (A29.11), microscale synthetic swimmers (B29.2), plastic-explosive-degrading enzyme (P26.4), Cooper-pair molasses (Z39.11), double electromagnetically induced transparency (N43.1), vortex-phase qubits (B43.13), novel skin cream (C1.131), and antimicrobial coatings for medical devices (G29.5).

A Nobel Prize symposium (session G1a) entitled "One Hundred Year
'"/>

Contact: James Riordon
riordon@aps.org
301-209-3238
American Physical Society
17-Mar-2006


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology news :

1. Unraveling the physics of DNAs double helix
2. Pendulum love, science class gender gaps, musical mind mirrors, and unparticle physics
3. Manchester to spearhead 8.3 million particle physics project
4. Press conferences at the years largest physics meeting
5. Largest physics meeting of the year, in Denver
6. Protein folding physics, nanohandles, sunscreen for algae and classical quantum weirdness
7. Technique used commonly in physics finds application in neuroscience
8. What do Racquel Welch and quantum physics have in common?
9. APS physics tip sheet #62
10. Unified physics theory explains animals running, flying and swimming
11. APS physics tip sheet #57

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biggest physics meeting the year

(Date:5/24/2013)... Modulating the immune system to combat metastatic cancer ... and destruction by the immune system. Stimulation of the ... there are many factors that cause the immune system ... cells that function to suppress the immune system response. ... Investigation , researchers led by Ronald Levy at Stanford ...
(Date:5/24/2013)... non-coding RNAs are small molecules that help control ... they have emerged as disease biomarkers. miRNA profiles ... cancers of unknown primary origin, determine prognosis, monitor ... tractable, diagnostic methods for monitoring miRNA expression in ... issue of the Journal of Clinical Investigation ...
(Date:5/24/2013)... Alzheimer,s disease, scientists have focused among other factors ... all, it is the accumulation of A-beta that causes the ... for the formation of A-beta is APP. Alessia Soldano and ... function of APPL the fruit-fly version of APP ... Soldano (VIB/KU Leuven): "We have discovered that APPL ensures that ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8A new strategy required in the search for Alzheimer's drugs? 2
(Date:5/23/2013)... , May 23, 2013 VG ... strategic alliance with DAK Renewable Research to conduct ... oil yield. VG Energy is a majority owned ... VGLS). VG Energy,s exclusively licensed compound ... the oil yield in plants, possessing a wide ...
(Date:5/23/2013)... 2013 BioTrends Research Group, one of ... specialized biopharmaceutical issues, finds that, unaided, one in ... reported that in the past six months, they ... in anticipation of the next generation of HCV ... only 6 percent reported that they had begun ...
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... developing DCVax ® personalized immune therapies for solid ... exhibit at this year,s American Society Of Clinical Oncology ... highlight its leadership role in immune therapy.  ... annual meeting is the pre-eminent conference focused on clinical ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013  Verenium ... biotechnology company focused on the development and commercialization of ... , Chief Financial Officer, will present at two ... Mr. Black will present at the Second Annual ... at the Grand Hyatt Hotel in New York City.  ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3
Cached News: